← The Wire
ASNDNasdaq
Ascendis Pharma A/S
Pharmaceutical Preparations · G7 · CIK 1612042
Ascendis Pharma A/S develops and commercializes innovative therapies using its TransCon technologies
$14.30B
Market cap
$263.70
Last close
+1.1%
1D
+15.7%
5D
1.1M
Volume
Price · last 39 sessions+15.3%
May 4L $205.81 · H $263.70Jun 29
462
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 29, 20266-K6-KJun 17, 20266-K6-KJun 15, 20266-K6-KJun 12, 20266-K6-KJun 10, 20266-K6-KMay 13, 20266-K6-KMay 7, 20266-K6-KMay 7, 20266-K6-KApr 21, 20266-K6-KApr 21, 20266-K6-KApr 20, 20266-K6-KApr 16, 20266-K6-KApr 8, 20266-K6-KApr 8, 20266-K6-KApr 7, 20266-K6-KMar 30, 20266-K6-KMar 24, 20266-K6-KMar 17, 20266-K6-KMar 16, 20266-K6-KMar 11, 20266-K6-KMar 2, 20266-K6-KFeb 23, 20266-K6-KFeb 11, 202620-F20-FFeb 11, 20266-K6-KFeb 11, 20266-K6-KJan 14, 20266-K6-KJan 12, 20266-K6-KJan 9, 20266-K6-KDec 30, 20256-K6-KDec 10, 20256-K6-KNov 26, 20256-K6-KNov 12, 20256-K6-KNov 12, 20256-K6-KNov 12, 20256-K6-KOct 22, 20256-K6-KOct 15, 20256-K6-KOct 8, 20256-K6-KSep 30, 20256-K6-KSep 10, 20256-K6-KAug 13, 20256-K6-KAug 7, 20256-K6-KAug 7, 20256-K6-KJul 28, 20256-K6-KJul 9, 20256-K6-KJun 27, 20256-K6-KJun 11, 20256-K6-KJun 9, 20256-K6-KJun 9, 20256-K6-KJun 2, 20256-K6-KMay 28, 20256-K6-KMay 14, 20256-K6-KMay 1, 20256-K6-KMay 1, 20256-K6-KApr 29, 20256-K6-KApr 9, 20256-K6-KMar 31, 20256-K6-KMar 28, 20256-K6-KMar 20, 20256-K6-KMar 12, 202520-F20-FFeb 12, 20256-K6-KFeb 12, 20256-K6-KFeb 12, 20256-K6-KFeb 12, 20256-K6-KJan 15, 20256-K6-KJan 13, 20256-K6-KJan 13, 20256-K6-KDec 30, 20246-K6-KDec 17, 20246-K6-KDec 12, 20246-K6-KDec 11, 20246-K6-KNov 14, 20246-K6-KNov 14, 20246-K6-KNov 13, 20246-K6-KNov 4, 20246-K6-KOct 9, 20246-K6-KSep 30, 20246-K6-KSep 27, 20246-K6-KSep 23, 2024424B5424B5Sep 20, 2024424B5424B5Sep 18, 2024
Similar companies
Comparable business profile · signals at a glance